The vascular and biochemical effects of cilostazol in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages 1226-1234

  O'Donnell, Mark E ^a   Badger, Stephen A ^a   Sharif, Mohammed A ^a   Young, Ian S ^b   Lee, Bernard ^a   Soong, Chee V ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CILOSTAZOL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; BLOOD CLOTTING TEST; CLAUDICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HEART PALPITATION; HUMAN; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; TISSUE OXYGENATION; TREADMILL EXERCISE; UREA BLOOD LEVEL; WALKING; WALKING DIFFICULTY;

ADULT; AGED; AGED, 80 AND OVER; ANKLE; AORTA; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR AGENTS; COMPLIANCE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OXYGEN; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECOVERY OF FUNCTION; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 64949096705     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.098     Document Type: Article

References (37)

1. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
2. Schmieder F.A., and Comerota A.J. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiol 87 (2001) 3D-13D
3. Schror K. The pharmacology of cilostazol. Diabetes Obes Metab 4 suppl 2 (2002) S14-S19
4. Chapman T.M., and Goa K.L. Cilostazol: a review of its use in intermittent claudication. Am J Cardiovasc Drugs 3 (2003) 117-138
5. Thompson P.D., Zimet R., Forbes W.P., and Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 90 (2002) 1314-1319
6. Liu Y., Shakur Y., Yoshitake M., and Kambayashi Ji J. Cilostazol (Pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. Cardiovas Drug Rev 19 (2001) 369-386
7. Reilly M.P., and Mohler III E.R. Cilostazol: treatment of intermittent claudication. Ann Pharmacother 35 (2001) 48-56
8. Robless P., Mikhailidis D.P., and Stansby G.P. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev (2008) CD003748
9. Mohler III E.R., Beebe H.G., Salles-Cuhna S., Zimet R., Zhang P., Heckman J., et al. Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication. Vasc Med 6 (2001) 151-156
10. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 suppl 1 (2007) S1-S75
11. Otsuka-Pharmaceuticals. Pletal: Prescribing Information (2003). www.otsuka-us.com/documents/Pletal_PI.pdf
12. Wilkinson I.B., MacCallum H., Flint L., Cockcroft J.R., Newby D.E., and Webb D.J. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525 (2000) 263-270
13. Wilkinson I.B., Fuchs S.A., Jansen I.M., Spratt J.C., Murray G.D., Cockcroft J.R., and Webb D.J. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 16 (1998) 2079-2084
14. Filipovsky J., Svobodova V., and Pecen L. Reproducibility of radial pulse wave analysis in healthy subjects. J Hypertens 18 (2000) 1033-1040
15. Pannier B.M., Avolio A.P., Hoeks A., Mancia G., and Takazawa K. Methods and devices for measuring arterial compliance in humans. Am J Hypertens 15 (2002) 743-753
16. O'Rourke M.F. Wave travel and reflection in the arterial system. J Hypertens 17 (1999) S45-S47
17. Segers P., Qasem A., De Backer T., Carlier S., Verdonck P., and Avolio A. Peripheral "oscillatory" compliance is associated with aortic augmentation index. Hypertension 37 (2001) 1434-1439
18. Karamanoglu M., O'Rourke M.F., Avolio A.P., and Kelly R.P. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 14 (1993) 160-167
19. Takazawa K., O'Rourke M.F., Fujita M., Tanaka N., Takeda K., Kurosu F., et al. Estimation of ascending aortic pressure from radial arterial pressure using a generalised transfer function. Z Kardiol 85 suppl 3 (1996) 137-139
20. Mullan B.A., Young I.S., Fee H., and McCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40 (2002) 804-809
21. Carrington A.L., Abbott C.A., Griffiths J., Jackson N., Johnson S.R., Kulkarni J.V., et al. Peripheral vascular and nerve function associated with lower limb amputation in people with and without diabetes. Clin Sci (Lond) 101 (2001) 261-266
22. Morgan M.B., Crayford T., Murrin B., and Fraser S.C. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33 (2001) 679-687
23. Ware Jr. J.E., Kosinski M., Bayliss M.S., McHorney C.A., Rogers W.H., and Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33 4 suppl (1995) AS264-AS279
24. Regensteiner J.G., Ware Jr. J.E., McCarthy W.J., Zhang P., Forbes W.P., Heckman J., et al. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials. J Am Geriatric Soc 50 (2002) 1939-1946
25. Dawson D.L., Cutler B.S., Meissner M.H., and Strandness Jr. D.E. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 98 (1998) 678-686
26. Kelly R., Hayward C., Avolio A., and O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80 (1989) 1652-1659
27. Nichols W., and O'Rourke M. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. (1998), Arnold, London, UK
28. Carr A.C., and Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 69 (1999) 1086-1107
29. Bacharach J.M., Rooke T.W., Osmundson P.J., and Gloviczki P. Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg 15 (1992) 558-563
30. Bunt T.J., and Holloway G.A. TcPO2 as an accurate predictor of therapy in limb salvage. Ann Vasc Surg 10 (1996) 224-227
31. de Groote P., Millaire A., Deklunder G., Marache P., Decoulx E., and Ducloux G. Comparative diagnostic value of ankle-to-brachial index and transcutaneous oxygen tension at rest and after exercise in patients with intermittent claudication. Angiology 46 (1995) 115-122
32. Reid J.A., Wolsley C., Lau L.L., Hannon R.J., Lee B., Young I.S., et al. The effect of pravastatin on intima media thickness of the carotid artery in patients with normal cholesterol. Eur J Vasc Endovasc Surg 30 (2005) 464-468
33. Gardner A.W., and Poehlman E.T. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 274 (1995) 975-980
34. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
35. Feinberg R.L., Gregory R.T., Wheeler J.R., Snyder Jr. S.O., Gayle R.G., Parent III F.N., et al. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg 16 (1992) 244-250
36. Beebe H.G., Dawson D.L., Cutler B.S., Herd J.A., Strandness Jr. D.E., Bortey E.B., et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med 159 (1999) 2041-2050
37. Hiatt W. The US experience with cilostazol in treating intermittent claudication. Atherosclerosis 6 (2006) 21-31